U.S. Retail REITs Stock News

Recent analyst coverage has pushed Cheesecake Factory (CAKE) into focus for growth oriented investors, highlighting favorable growth scores and a track record of positive earnings surprises ahead of its late July 2026 earnings report. See our latest analysis for Cheesecake Factory. The recent 36.84% 3 month share price return and 62.41% year to date share price return to about $85.77 suggest momentum has been building around Cheesecake Factory as investors react to its earnings track record...

On July 9, 2026, Biohaven Ltd. announced that Chief Scientific Officer Bruce Car, Ph.D., had retired from that role on July 13, 2026 to become part-time Chief Innovation Officer, while David Pirman, Ph.D., was promoted to Executive Vice President and Head of Discovery and General Counsel Warren Volles was designated an executive officer. This reshaped leadership structure separates external innovation and collaborations from internal discovery operations, clarifying how Biohaven intends to...

Skyward Specialty Insurance Group expands share repurchase capacity Skyward Specialty Insurance Group (SKWD) has doubled its share repurchase authorization to $100 million, a move that signals management confidence and places capital returns more firmly on the radar for investors. See our latest analysis for Skyward Specialty Insurance Group. The repurchase expansion comes after a strong run in Skyward Specialty Insurance Group’s share price, with a 30 day share price return of 17.22% and a 3...

Collegium Pharmaceutical stock has delivered a 59.6% total return over the past three years, yet its current checks point to pricing that looks broadly in line with the market rather than clearly cheap or clearly expensive. The 59.6% three year return suggests investors who stayed invested in Collegium Pharmaceutical have been rewarded, which raises the bar for what the current share price needs to justify. Future expectations for Collegium Pharmaceutical's revenue growth and cash generation...

Ulta Beauty (ULTA) has drawn fresh attention after appointing board member Kelly Garcia as chief technology officer. The move is tied to its Ulta Beauty Unleashed technology ambitions and the stock’s recent strength versus a weaker broader market. See our latest analysis for Ulta Beauty. The appointment of Kelly Garcia as CTO comes as Ulta Beauty’s share price shows mixed momentum, with a 30 day share price return of 6.39% but a year to date share price decline of 22.66%. The 5 year total...

Calumet (CLMT) is back on investors’ radar after Calumet Specialty Products Partners and Calumet Finance Corp. moved to redeem all $100 million of their 9.75% Senior Notes due 2028 at a premium in mid July. See our latest analysis for Calumet. The redemption news comes as Calumet’s share price trades at $42.83, with a 1 day share price return of 4.26% and a 30 day share price return of 29.20%. This has contributed to a stronger year to date share price return of 119.08% and a 1 year total...

Ecolab stock has delivered a 48.8% total return over the past three years, and at around US$272.83 per share the key question is whether that run now leaves it trading close to its intrinsic value or at a premium. The Discounted Cash Flow (DCF) estimate points to Ecolab being roughly fairly valued, while the broader valuation checks and market multiples lean more cautious. Ecolab's 48.8% return over three years means anyone who stayed invested has been rewarded, so fresh buyers now need to...

In July 2026, General Mills, ADM and Walmart announced a collaboration to expand regenerative agriculture across 40,000 Midwest wheat acres, offering farmers technical support and financial incentives to adopt practices such as no-till and cover crops. This three-way effort links ADM’s role as a major wheat supplier and manager of nearly 5 billion regenerative acres globally with large downstream buyers, creating a proof-of-concept for scaling sustainability across an integrated food supply...

RBC Capital recently downgraded ResMed to Sector Perform from Outperform, pointing to FY27 pressures from Astral ventilator replacements, higher input costs, and supply constraints on key components. The downgrade highlights how operational issues in a single product line can ripple through device sales, cost structure, and overall business planning for the coming years. Next, we’ll examine how expected FY27 cost pressures and supply bottlenecks may influence ResMed’s previously optimistic...

Coinbase Global (COIN) is back in focus after a series of leadership shifts, including changes at its Base platform and in senior legal roles, which coincide with heightened debate over US crypto regulation. See our latest analysis for Coinbase Global. Those leadership changes at Coinbase Global come after a period where momentum has cooled, with the share price down 23.85% over 90 days and year to date, and a 1 year total shareholder return down 62.57%, even though the 3 year total...

Ichor Holdings (ICHR) has drawn investor attention after recent share price moves, with the stock down 1.0% over the past day and 17.4% over the past week, following a period of strong multiyear total returns. See our latest analysis for Ichor Holdings. Zooming out, Ichor Holdings has seen its recent momentum fade, with the share price down 7.4% over the past month and 17.4% over the past week. However, the year to date share price return of 306.0% and 1 year total shareholder return of...

Recent commentary around eBay (EBAY) has focused on softer active buyer growth, a weaker sales outlook and rising expenses outpacing revenue, which is pressuring EBITDA margins and prompting investors to reassess the stock’s recent share price gains. See our latest analysis for eBay. At a latest share price of US$112.06, eBay’s 1 day share price return of 1.04% comes after a softer 7 day share price return of 4.39%. However, the year to date share price return of 28.72% and 1 year total...

Equinix, Inc. announced that Chief Business Officer Jon Lin left the company on July 18, 2026, with his responsibilities redistributed among existing senior leaders and plans underway to appoint a new Chief Product Officer to oversee product strategy and governance. This leadership reshuffle highlights Equinix’s emphasis on continuity and product focus as it manages executive turnover while maintaining its existing operating structure. Next, we’ll examine how this leadership transition,...

Citigroup Inc. recently reported stronger second-quarter 2026 results, with higher net interest income, net income, and earnings per share, while also announcing a full US$1.50 billion redemption of its 6.250% Series T preferred stock in August 2026 as part of its funding and capital-structure optimization. At the same time, Citi expanded its fixed-income funding and advanced its digital payments and tokenization efforts, suggesting a tighter focus on capital efficiency, funding flexibility,...

Resideo Technologies has nearly doubled investors' money over the past three years, and the current valuation checks suggest the stock still trades at a discount, with the Discounted Cash Flow (DCF) intrinsic value estimate indicating room above the recent US$35.83 share price. Resideo Technologies has returned 98.4% over the past three years, which puts extra focus on whether that gain is fully backed by fundamentals. The planned spin off of the ADI Global Distribution business may support...

Voter support is tilting toward democratic socialist policies like universal healthcare, higher taxes on the wealthy, and more government-backed services, and that puts parts of the healthcare sector squarely under the spotlight. For investors, the bigger question is how potential future reforms and tougher oversight could affect margins, pricing power, and long term business models. This article examines the political catalysts behind this shift and then outlines 3 healthcare stocks that...

Analyst Optimism Builds Ahead of Pool Corp Earnings Recent optimism around Pool (POOL) centers on its upcoming June-quarter earnings report, with expectations for higher revenue and a year over year EPS increase drawing fresh attention to the stock. See our latest analysis for Pool. Despite the upbeat earnings expectations, Pool's recent share price performance has been weak, with the stock closing at US$201.17 and the 1 year total shareholder return down 31.18%, which points to fading...

Fidelity National Information Services (FIS) has joined Project Glasswing, using Anthropic’s Mythos 5 frontier AI model to help identify security vulnerabilities in its infrastructure and support wider efforts around defensive cybersecurity in financial services. See our latest analysis for Fidelity National Information Services. These security and product updates come after a mixed period for Fidelity National Information Services. The share price is at US$41.91, with a 1 month share price...

Assurant stock has delivered a strong 124.2% return over the past three years, yet the valuation picture is split, with the Excess Returns intrinsic value estimate pointing to meaningful upside while market multiples suggest the shares trade at a premium. Over three years, Assurant has returned 124.2%, which puts extra focus on whether today’s price still leaves room for attractive risk adjusted returns. Upcoming earnings, where analysts expect pressure on EPS, may influence views on the...

Stryker stock has given investors a 28.3% total return over the past five years, yet its current share price around US$319 sits at a point where the Discounted Cash Flow (DCF) estimate suggests room for upside, while the broader checks paint a more cautious picture. A 28.3% return over five years indicates that Stryker has rewarded patient shareholders without delivering an outsized run that would obviously stretch valuation. The launch of the Mako RPS handheld robotic system can support...

Earlier in July 2026, U.S. regulators expanded approval of Vertex’s gene-editing therapy Casgevy to children as young as 2 with sickle cell disease or transfusion-dependent thalassemia, while Canada’s pan-Canadian Pharmaceutical Alliance signed a Letter of Intent with Vertex to enable public reimbursement discussions for its cystic fibrosis therapy ALYFTREK. These moves deepen Vertex’s reach in severe genetic diseases by both widening the eligible patient pool for Casgevy and advancing payer...

S&P Global stock has delivered a 5 year return of 18.8%, yet its valuation checks currently lean expensive, which raises the question of how much of the story around new products and operating changes is already reflected in the US$450.84 share price. That 18.8% return over five years suggests S&P Global has rewarded patient shareholders, but not at a pace that clearly justifies paying any price for future growth. New offerings such as ETF Intelligence and a refreshed Market Intelligence...

Ameris Bancorp (ABCB) heads into its next earnings report on July 23 with expectations for higher year over year earnings and revenue, putting fresh attention on how the stock prices in those forecasts. See our latest analysis for Ameris Bancorp. The recent 7 day share price return of 2.10% and 30 day share price return of 7.32% suggest momentum has been building in Ameris Bancorp ahead of its earnings update. At the same time, the 1 year total shareholder return of 38.48% and 3 year total...

LGI Homes has opened The Meadows at Riverside, a new single-family home community in Falling Waters featuring six upgraded floor plans and extensive outdoor amenities, with a grand opening event held on July 11–12, 2026. This launch underscores LGI Homes’ emphasis on amenity-rich, move-in-ready homes that bundle upgrades like granite countertops and energy-efficient features into its CompleteHome Plus package. We’ll now examine how this new amenity-rich community opening, with its bundled...